During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...

Ben Trotman’s tumor is completely gone after participating in a clinical trial to treat glioblastoma, one of the deadliest ...

While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...

Dispatch Bio has unveiled with $216 million and the lofty goal of creating a universal treatment for solid tumors using a new immunotherapy approach. | Dispatch Bio has unveiled with $216 million and ...

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — on every cancer cell in a patient's body.